Renal tubular dysfunction in COVID-19 patients

Ir J Med Sci. 2023 Apr;192(2):923-927. doi: 10.1007/s11845-022-02993-0. Epub 2022 Apr 14.

Abstract

Introduction: SARS-CoV-2 infection can affect other organs aside from those of respiratory system, particularly the kidney, heart, blood, digestive tract, and nervous system. COVID-19 renal compromise consists of different syndromes since proteinuria, hematuria, and acute kidney injury (AKI), until chronic kidney disease. Since COVID-19-induced renal tubular damage has been described as a potential antecedent condition to AKI installation, it was decided to evaluate how COVID-19 affects tubular function.

Materials and method: Serum inflammatory parameters, urinalysis, and classical urinary indexes in COVID-19 admitted patients who had neither AKI nor chronic kidney disease (CKD) were evaluated. Statistical analysis was performed by applying Student t test.

Results: Renal tubular function was evaluated in 41 COVID-19 admitted patients who had neither AKI nor CKD. Patients' mean age was 56 years, males (79%), and with normal creatininemia (0.8 ± 0.2 mg/dL) and eGFR (105.7 ± 6.5 mL/min) values. It was found mild hypocalcemia and a relative increased fractional excretion (FE) of sodium, FE of calcium, FE of phosphorus, calcium-creatinine index, urinary osmolarity, and relative alkaline urine pH values.

Conclusion: Tubular dysfunction was documented in COVID-19 patients.

Keywords: COVID-19; Electrolytes; Tubular function.

MeSH terms

  • Acute Kidney Injury*
  • COVID-19* / complications
  • Calcium
  • Humans
  • Male
  • Middle Aged
  • Renal Insufficiency, Chronic*
  • SARS-CoV-2

Substances

  • Calcium